Reunion Neuroscience Inc.
REUN · NASDAQ
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $4 | $3 | $2 | $3 |
| G&A Expenses | $4 | $3 | $4 | $2 |
| SG&A Expenses | $4 | $3 | $4 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | -$2 | $4 | $0 | $0 |
| Operating Expenses | $7 | $10 | $6 | $5 |
| Operating Income | -$7 | -$10 | $3 | -$5 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | -$3 | -$16 | -$0 |
| Pre-Tax Income | -$6 | -$12 | -$14 | -$5 |
| Tax Expense | -$0 | $0 | $10 | $0 |
| Net Income | -$6 | -$13 | -$24 | -$5 |
| % Margin | – | – | – | – |
| EPS | -0.54 | -1.09 | -2.05 | -0.45 |
| % Growth | 50.5% | 46.8% | -355.6% | – |
| EPS Diluted | -0.54 | -1.09 | -2.05 | -0.45 |
| Weighted Avg Shares Out | 12 | 12 | 12 | 12 |
| Weighted Avg Shares Out Dil | 12 | 12 | 12 | 12 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | -$0 | $0 | $0 | $0 |
| Depreciation & Amortization | -$2 | $4 | -$10 | $1 |
| EBITDA | -$8 | -$9 | -$7 | -$4 |
| % Margin | – | – | – | – |